University of Southern California public policy professor Genevieve Kanter airs concerns about the impact of the many changes that have occurred at FD...
An industry consultant says reduced FDA staffing levels and high turnover are extending regulatory timelines and forcing drug developers to invest mor...
Axios reports that the vice chair of the CDC Advisory Committee on Immunization Practices says the Pfizer and Moderna Covid mRNA vaccines should be re...
A Congressional Research Service backgrounder explains options Congress could consider to resolve some issues with the skinny label provision in the W...
FDA posts an updated guidance clarifying when clinical decision support software functions fall outside the definition of a regulated medical device.
FDA approves Tenpoint Therapeutics Yuvezzi as the only combination eye drop approved to treat presbyopia in adults.
FDA accepts for review a Summit Therapeutics BLA seeking approval for ivonescimab in combination with chemotherapy in patients with epidermal growth f...
CDRH reports on its 2025 MDUFA 5 activities to promote international harmonization.
